Literature DB >> 9865714

Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells.

M Y Janssens1, D L Van den Berge, V N Verovski, C Monsaert, G A Storme.   

Abstract

EMT-6 cells treated for 16 h with 1-10 units/ml IFN-gamma showed a gradual activation of inducible nitric oxide synthase (iNOS) in Western and Northern blots, a simultaneous raise in NO output, and an increase in hypoxic cell radiosensitivity almost to the level of aerobic cells. Both the NO signal and radiosensitization were counteracted by the NO scavenger oxyhemoglobin, by the specific iNOS inhibitor aminoguanidine, and by the L-arginine analogue N(G)-monomethyl-L-arginine. Collectively, these data demonstrate that IFN-gamma can radiosensitize EMT-6 cells through iNOS induction and that NO is the effector molecule responsible for radiosensitization. Compared with the spontaneous NO releaser (2)-1-[N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-1-ium -1,2-diolate], the iNOS-generated NO signal appeared to be 10 times lower yet resulting in the same enhancement ratio of 2.4. Direct stimulation of NO synthesis in tumor cells through the L-arginine/iNOS pathway represents a novel approach to exploit the radiosensitizing properties of NO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865714

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Hypoxic tumor microenvironment: Implications for cancer therapy.

Authors:  Sukanya Roy; Subhashree Kumaravel; Ankith Sharma; Camille L Duran; Kayla J Bayless; Sanjukta Chakraborty
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-27

2.  CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.

Authors:  Xiaoli Li; Dan Liu; Xin Liu; Weiwei Jiang; Weiying Zhou; Wei Yan; Yanyan Cen; Bin Li; Guanqun Cao; Guofu Ding; Xueli Pang; Jianguo Sun; Jiang Zheng; Hong Zhou
Journal:  Tumour Biol       Date:  2012-06-28

3.  Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.

Authors:  Yong-Zhong Wang; You-Qing Cao; Jian-Nong Wu; Miao Chen; Xiao-Ying Cha
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

4.  Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase.

Authors:  D L Berge; M De Ridder; V N Verovski; M Y Janssens; C Monsaert; G A Storme
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

5.  A hybrid semiconducting organosilica-based O2 nanoeconomizer for on-demand synergistic photothermally boosted radiotherapy.

Authors:  Wei Tang; Zhen Yang; Liangcan He; Liming Deng; Parinaz Fathi; Shoujun Zhu; Ling Li; Bo Shen; Zhantong Wang; Orit Jacobson; Jibin Song; Jianhua Zou; Ping Hu; Min Wang; Jing Mu; Yaya Cheng; Yuanyuan Ma; Longguang Tang; Wenpei Fan; Xiaoyuan Chen
Journal:  Nat Commun       Date:  2021-01-22       Impact factor: 14.919

6.  Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.

Authors:  Hiroshi Maeda; Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-03-01

7.  Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption.

Authors:  Sven de Mey; Heng Jiang; Cyril Corbet; Hui Wang; Inès Dufait; Kalun Law; Estelle Bastien; Valeri Verovski; Thierry Gevaert; Olivier Feron; Mark De Ridder
Journal:  Front Pharmacol       Date:  2018-10-03       Impact factor: 5.810

8.  NF-kappaB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase.

Authors:  M De Ridder; D L Van den Berge; V N Verovski; C Monsaert; N Wauters; G A Storme
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.